BristolMyers Squibb Taps AI Partnership with Anthropic as Hedge Funds Eye Its 425 Dividend Yield Googles Homepage Redesign Signals Deeper AI Integration in Search Japans Megabanks Hit Record Profits but Analysts Flag Potential Headwinds From Credit Costs and Geopolitical Risks PutinXi Talks to Address Stalled Power of Siberia 2 Pipeline Amid Energy Market Turmoil White House Announces Soybean and Rare Earth Deals After TrumpXi Summit China Signals Potential Tariff Reductions SpaceX Faces A Crucial Launch Test Ahead Of Its IPO ITP Q3 2025 Earnings Net Loss Reported Amid Limited Financial Data SII Q1 2026 Earnings EPS Surprises Upward Despite Broader Market Headwinds ACLX Q4 2025 Earnings EPS Beat Amid Continued RD Investment Apple Hospitality REIT APLE Q1 2026 Earnings EPS Misses Estimates Yet Shares Rise 235 Nephros Q1 2026 Earnings EPS Misses Estimates by a Hair Shares Edge Higher HEI Q1 2026 Earnings EPS Surpasses Estimates Amid Strong Aerospace Demand Live Ventures Slips Again Support Level at 101 Holds the Key for a Potential Reversal Strategy Inc Preferred Stock STRF Holds Near Resistance Amid Perpetual Preferred Stability Montauk Renewables Surges 8 Is a Breakout to 184 Imminent Natuzzi NTZ Declines 32 as Stock Nears Key Support Level Myseum Inc MYSE Gains Ground After Positive Price ActionSupport and Resistance Levels in Focus Illinois Unemployment Rate Holds Steady in September Payroll Employment Shows Minimal Change FOXF Q1 2026 Earnings EPS Beats Estimates by 1153 Amid Cost Discipline Rocky Brands RCKY Posts 324 Gain Is a Breakout Toward Resistance Underway BORR Q1 2026 Earnings Earnings Misses Estimates as Loss Widens RVMD Q1 2026 Earnings EPS Miss Reflects Increased RD Spending Pipeline Progress Continues Protara Therapeutics Q1 2026 Earnings EPS Beat Despite No Revenue Stock Declines USAC Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds Under Armour Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Restructuring ConocoPhillips COP Q1 2026 Earnings EPS Beats Estimates by 1323 as Operational Efficiency Drives Profitability Stock Slips Slightly Protara Therapeutics TARA Q1 2026 Earnings Narrower Loss Beats Street Estimates on Cost Management